Inozyme Pharma Stock

inozyme.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $115.85MM

Inozyme Pharma is a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases.

Register To Buy and Sell Shares

For more details on financing and valuation for Inozyme Pharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Inozyme Pharma’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Inozyme Pharma.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Henric Bjarke
Chief Operating Officer & Senior Vice President
Stephen Basso
Vice President of Finance
Joseph Schlessinger Ph.D
Co-Founder & Chairman
Steven Jungles
Chief Technical Operations Officer & Senior Vice President
David Thompson
Senior Vice President & Chief Scientific Officer
Eric Yuen MD
Chief Medical Officer & Senior Vice President
Axel Bolte
Co-Founder, Chief Executive Officer, President & Board Member
Ruhi Ahmed Ph.D
Vice President of Regulatory and Government Affairs
Demetrios Braddock Ph.D
Scientific Founder, Chairperson of Scientific Advisory Board and Board Observer

Board Members

Axel Bolte
Joseph Schlessinger Ph.D
Rob Hopfner
Demetrios Braddock Ph.D
Martin Edwards MD
Novo Holdings
Ruchita Sinha
Sanofi-Genzyme Bioventures
Edward Mathers
New Enterprise Associates
Reinaldo Diaz
Longitude Capital
Sarah Bhagat Ph.D
Sofinnova Investments

Frequently Asked Questions About Inozyme Pharma’s Stock

Can you buy Inozyme Pharma’s stock?
Inozyme Pharma is not publicly traded on NYSE or NASDAQ in the U.S. To buy Inozyme Pharma’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Inozyme Pharma’s stock?
Yes, you can sell stock of a private company like Inozyme Pharma. Forge can help you sell your Inozyme Pharma stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Inozyme Pharma’s stock price?
Inozyme Pharma is a privately held company and therefore does not have a public stock price. However, you may access Inozyme Pharma’s private market stock price with Forge Data.
What is Inozyme Pharma’s stock ticker symbol?
Inozyme Pharma does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Inozyme Pharma Expands Medical Leadership Team
Inozyme Pharma today announced the addition of three industry veterans to its leadership team.
Updated on: Feb 29, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.